![](https://bluewillow.com/wp-content/uploads/2016/02/medical-team-1-495x400.jpg)
NanoBio Announces Data Presentation on Its Nanoemulsion Adjuvanted RSV Vaccine at IDWeek 2012
ANN ARBOR, Mich. and SAN DIEGO (October 15, 2012) - NanoBio Corporation…
![](https://bluewillow.com/wp-content/uploads/2016/02/medical-team-1-495x400.jpg)
NanoBio Promotes David Peralta to Chief Executive Officer
ANN ARBOR, Mich. (October 9, 2012) - NanoBio® Corporation today…
![](https://bluewillow.com/wp-content/uploads/2016/02/medical-team-1-495x400.jpg)
NanoBio to Report Data on Its Nanoemulsion Adjuvanted Intranasal RSV Vaccine at the 8th Annual International Respiratory Syncytial Virus Symposium
ANN ARBOR, Mich. and SANTA FE, N.M. (September 24, 2012) - NanoBio®…
![](https://bluewillow.com/wp-content/uploads/2016/02/medical-team-1-495x400.jpg)
NanoBio to Present Preclinical Data on Its Nanoemulsion Adjuvanted Intranasal RSV Vaccine and Novel Inhaled Cystic Fibrosis Therapy at 52nd Annual ICAAC Meeting
ANN ARBOR, Mich. (September 10, 2012) - NanoBio Corporation announced…
![](https://bluewillow.com/wp-content/uploads/2016/02/medical-team-1-495x400.jpg)
A nice post
Lorem ipsum dolor sit amet, consectetuer adipiscing elit. Aenean…
Announcements and News
- Intranasal nanoemulsion adjuvanted S-2P vaccine demonstrates protection in hamsters and induces systemic, cell-mediated and mucosal immunity in mice
- BlueWillow Announces Promising Results for Intranasal Covid-19 Booster Vaccine
- BlueWillow Biologics Presents Positive Interim Anthrax Phase 1 Data to BARDA
Contact
BlueWillow Biologics
2311 Green Rd.
Ann Arbor, Mich. 48105
734-302-4000
734-302-9150 fax